NEW HAVEN, Conn., Aug. 2, 2011 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, will release second quarter 2011 financial results on Monday, August 8, 2011 after the U.S. financial markets close. Achillion executives will host a conference call and simultaneous webcast on Tuesday, August 9, 2011 at 10:30 a.m. EDT to review the financial results and to provide an update on Achillion’s portfolio of HCV compounds and upcoming milestones.
